Avalo Therapeutics
AVTX
AVTX
43 hedge funds and large institutions have $10.9M invested in Avalo Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 18 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
81% less capital invested
Capital invested by funds: $56.2M → $10.9M (-$45.2M)
Holders
43
Holding in Top 10
–
Calls
$7K
Puts
–
Top Buyers
| 1 | +$506K | |
| 2 | +$142K | |
| 3 | +$63.1K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$29.8K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$22K |
Top Sellers
| 1 | -$1.26M | |
| 2 | -$869K | |
| 3 | -$554K | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
-$507K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$503K |